UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 13, 2026 4:30 P.M.
Form:
F-1
CIK:
0002029039
Company Name:
Nasus Pharma Ltd
File Number:
333-293950